e-BioMatrix Canada Registry

CompletedOBSERVATIONAL
Enrollment

535

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2017

Conditions
Device Related MACE and Bleeding
Interventions
DEVICE

BioMatrix Flex

Percutaneous coronary intervention

Trial Locations (4)

V8R 4R2

Victoria Heart Institute Foundation, Victoria

M4N 3M5

Sunnybrook Health Sciences, Toronto

M5G 2C4

Toronto General Hospital, Toronto

H3A 1A1

Royal Victoria Hospital, Montreal

All Listed Sponsors
lead

Biosensors Europe SA

INDUSTRY

NCT01915628 - e-BioMatrix Canada Registry | Biotech Hunter | Biotech Hunter